{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:16:07Z","timestamp":1777554967856,"version":"3.51.4"},"reference-count":79,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Dermatitis\u00ae"],"published-print":{"date-parts":[[2012,10,1]]},"abstract":"<jats:p>Allergic contact dermatitis is the quintessential example of a delayed-in-time and T-cell\u2013mediated immune response. In the last decade, many of the molecular events required to initiate (or block) such a response have been uncovered. Textbook and journal reviews have emphasized the costimulatory requirements, with less focus on the coinhibitory signals that are of equal importance in understanding this central event of adaptive immunity. To fill this gap, we offer a compendium of discoveries characterizing the ligand-receptor pairs inhibiting T-cell activation and of selected illnesses and therapeutic applications that illuminate their role in health and disease.<\/jats:p>","DOI":"10.1097\/der.0b013e31826e43ed","type":"journal-article","created":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T12:03:59Z","timestamp":1397649839000},"page":"195-202","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["T-cell Inhibitors: A Bench-to-Bedside Review"],"prefix":"10.1177","volume":"23","author":[{"given":"Shinjita","family":"Das","sequence":"first","affiliation":[{"name":"From the Department of Dermatology, The University of Texas Southwestern Medical Center and Dallas Veterans Affairs Medical Center, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Ariizumi","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, The University of Texas Southwestern Medical Center and Dallas Veterans Affairs Medical Center, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Ponciano D.","family":"Cruz","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, The University of Texas Southwestern Medical Center and Dallas Veterans Affairs Medical Center, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2012,10,1]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2010.02.013"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.021908.132706"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.20.091101.091806"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1917"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxm057"},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.4049\/jimmunol.179.9.5778","article-title":"Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation","volume":"179","author":"Chung JS","year":"2007","unstructured":"Chung JS, , Dougherty I, , Cruz PDJr, et al. Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation. J Immunol, 2007; 179: 5778-5784.","journal-title":"J Immunol"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni988"},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/eji.200939274","article-title":"TIM-3 is expressed on activated CD4+ T cells and regulates TH1 and TH17 cytokines","volume":"39","author":"Hastings WD","year":"2009","unstructured":"Hastings WD, , Anderson DE, , Kassam N, et al. TIM-3 is expressed on activated CD4+ T cells and regulates TH1 and TH17 cytokines. Eur J Immunol, 2009; 39: 2492-2501.","journal-title":"Eur J Immunol"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1148536"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/328267a0"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.147.3.1037"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.3.561"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(94)90071-X"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.2.459"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90125-6"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1992.tb05481.x"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/10.10.1563"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80089-8"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.7.1027"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/85330"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni944"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni1144"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409071102"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-065X.2009.00783.x","article-title":"The CD160, BTLA, LIGHT\/HVEM pathway: a bidirectional switch regulating T-cell activation","volume":"229","author":"Cai G","year":"2009","unstructured":"Cai G, , Freeman G. The CD160, BTLA, LIGHT\/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol Rev, 2009; 229: 244-258.","journal-title":"Immunol Rev"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ni1418","article-title":"B and T lymphocyte attenuator regulates CD8+ T cell-intrinsic homeostasis and memory cell generation","volume":"8","author":"Krieg C","year":"2007","unstructured":"Krieg C, , Boyman O, , Fu YX, et al. B and T lymphocyte attenuator regulates CD8+ T cell-intrinsic homeostasis and memory cell generation. Nat Immunol, 2007; 8: 162-171.","journal-title":"Nat Immunol"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/415536a"},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni987","article-title":"TIM-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance","volume":"4","author":"Sanchez-Fueyo A","year":"2003","unstructured":"Sanchez-Fueyo A, , Tian J, , Picarella D, et al. TIM-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol, 2003; 4: 1093-1101.","journal-title":"Nat Immunol"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni1271"},{"key":"e_1_3_1_30_2","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1074\/jbc.M008539200","article-title":"Molecular cloning of a dendritic cell-associated transmembrane protein, DC-HIL, that promotes RGD-dependent adhesion of endothelial cells through recognition of heparan sulfate proteoglycans","volume":"276","author":"Shikano S","year":"2001","unstructured":"Shikano S, , Bonkobara M, , Zukas PK, et al. Molecular cloning of a dendritic cell-associated transmembrane protein, DC-HIL, that promotes RGD-dependent adhesion of endothelial cells through recognition of heparan sulfate proteoglycans. J Biol Chem, 2001; 276: 8125-8134.","journal-title":"J Biol Chem"},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1182\/blood-2006-11-053769","article-title":"DC-HIL is a negative regulator of T lymphocyte activation","volume":"109","author":"Chung JS","year":"2007","unstructured":"Chung JS, , Sato K, , Dougherty II, et al. DC-HIL is a negative regulator of T lymphocyte activation. Blood, 2007; 109: 4320-4327.","journal-title":"Blood"},{"key":"e_1_3_1_32_2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/eji.200838990","article-title":"The DC-HIL\/syndecan-4 pathway inhibits human allogeneic T-cell responses","volume":"39","author":"Chung JS","year":"2009","unstructured":"Chung JS, , Bonkobara M, , Tomihari M, et al. The DC-HIL\/syndecan-4 pathway inhibits human allogeneic T-cell responses. Eur J Immunol, 2009; 39: 965-974.","journal-title":"Eur J Immunol"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160062"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.05.009"},{"key":"e_1_3_1_35_2","doi-asserted-by":"crossref","first-page":"10113","DOI":"10.1073\/pnas.0711106105","article-title":"FOXP3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation","volume":"105","author":"Onishi Y","year":"2008","unstructured":"Onishi Y, , Fehervari Z, , Yamaguchi T, et al. FOXP3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci U S A, 2008; 105: 10113-10118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23674"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01621"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200939781"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-10-5"},{"key":"e_1_3_1_40_2","first-page":"2156","article-title":"Enhanced expression of programmed death-1 (PD-1)\/PD-L1 in salivary glands of patients with Sjogren\u2019s syndrome","volume":"32","author":"Kobayashi M","year":"2005","unstructured":"Kobayashi M, , Kawano S, , Hatachi S, et al. Enhanced expression of programmed death-1 (PD-1)\/PD-L1 in salivary glands of patients with Sjogren\u2019s syndrome. J Rheumatol, 2005; 32: 2156-2163.","journal-title":"J Rheumatol"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1020"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1399-0039.2003.00136.x"},{"key":"e_1_3_1_43_2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/art.20966","article-title":"A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese","volume":"52","author":"Kong EK","year":"2005","unstructured":"Kong EK, , Prokunina-Olsson L, , Wong WH, et al. A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum, 2005; 52: 1058-1062.","journal-title":"Arthritis Rheum"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20514"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.291.5502.319"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2007.02038.x"},{"key":"e_1_3_1_47_2","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.4049\/jimmunol.180.7.4409","article-title":"Lack of TIM-3 immunoregulation in multiple sclerosis","volume":"180","author":"Yang L","year":"2008","unstructured":"Yang L, , Anderson DE, , Kuchroo J, et al. Lack of TIM-3 immunoregulation in multiple sclerosis. J Immunol, 2008; 180: 4409-4414.","journal-title":"J Immunol"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20022125"},{"key":"e_1_3_1_49_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1189\/jlb.1107753","article-title":"BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice","volume":"86","author":"Truong W","year":"2009","unstructured":"Truong W, , Hancock WW, , Plester JC, et al. BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice. J Leukoc Biol, 2009; 86: 41-51.","journal-title":"J Leukoc Biol"},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1002\/art.23076","article-title":"Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts","volume":"56","author":"Seki M","year":"2007","unstructured":"Seki M, , Sakata KM, , Oomizu S, et al. Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum, 2007; 56: 3968-3976.","journal-title":"Arthritis Rheum"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.01.006"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.1.164"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.04.012"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000325915.00112.61"},{"key":"e_1_3_1_55_2","first-page":"117","article-title":"Suppression of murine allergic contact dermatitis by CTLA4Ig","volume":"157","author":"Tang A","year":"1996","unstructured":"Tang A, , Judge TA, , Nickoloff BJ, et al. Suppression of murine allergic contact dermatitis by CTLA4Ig. Tolerance induction of TH2 responses requires additional blockade of CD40-ligand. J Immunol, 1996; 157: 117-125.","journal-title":"Tolerance induction of TH2 responses requires additional blockade of CD40-ligand. J Immunol"},{"key":"e_1_3_1_56_2","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.4049\/jimmunol.165.4.1824","article-title":"Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance","volume":"165","author":"Schwarz A","year":"2000","unstructured":"Schwarz A, , Beissert S, , Grosse-Heitmeyer K, et al. Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance. J Immunol, 2000; 165: 1824-1831.","journal-title":"J Immunol"},{"key":"e_1_3_1_57_2","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.4049\/jimmunol.0903250","article-title":"Depleting syndecan-4+ T lymphocytes using toxin-bearing dendritic cell-associated heparan sulfate proteoglycan-dependent integrin ligand: a new opportunity for treating activated T cell-driven disease","volume":"184","author":"Akiyoshi H","year":"2010","unstructured":"Akiyoshi H, , Chung JS, , Tomihari M, et al. Depleting syndecan-4+ T lymphocytes using toxin-bearing dendritic cell-associated heparan sulfate proteoglycan-dependent integrin ligand: a new opportunity for treating activated T cell-driven disease. J Immunol, 2010; 184: 3554-3561.","journal-title":"J Immunol"},{"key":"e_1_3_1_58_2","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.4049\/jimmunol.175.9.5774","article-title":"Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts","volume":"175","author":"Tao R","year":"2005","unstructured":"Tao R, , Wang L, , Han R, et al. Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts. J Immunol, 2005; 175: 5774-5782.","journal-title":"J Immunol"},{"key":"e_1_3_1_59_2","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.4049\/jimmunol.169.11.6546","article-title":"Programmed death-1 targeting can promote allograft survival","volume":"169","author":"Ozkaynak E","year":"2002","unstructured":"Ozkaynak E, , Wang L, , Goodearl A, et al. Programmed death-1 targeting can promote allograft survival. J Immunol, 2002; 169: 6546-6553.","journal-title":"J Immunol"},{"key":"e_1_3_1_60_2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/CIRCULATIONAHA.107.741025","article-title":"Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy","volume":"117","author":"Yang J","year":"2008","unstructured":"Yang J, , Popoola J, , Khandwala S, et al. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy. Circulation, 2008; 117: 660-669.","journal-title":"Circulation"},{"key":"e_1_3_1_61_2","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/01.tp.0000250757.69384.79","article-title":"Gene transfer of programmed death ligand-1.Ig prolongs cardiac allograft survival","author":"Dudler J","year":"2006","unstructured":"Dudler J, , Li J, , Pagnotta M, et al. Gene transfer of programmed death ligand-1.Ig prolongs cardiac allograft survival. Transplantation, 2006; 82: 1733-1737.","journal-title":"Transplantation"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.7.4281"},{"key":"e_1_3_1_63_2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cellimm.2008.01.006","article-title":"The TIM-3 ligand galectin-9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graft","volume":"250","author":"Wang F","year":"2007","unstructured":"Wang F, , He W, , Zhou H, et al. The TIM-3 ligand galectin-9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graft. Cell Immunol, 2007; 250: 68-74.","journal-title":"Cell Immunol"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2008.01.008"},{"key":"e_1_3_1_65_2","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/TP.0b013e3181b47f25","article-title":"Galectin-9 significantly prolongs the survival of fully mismatched cardiac allografts in mice","volume":"88","author":"He W","year":"2009","unstructured":"He W, , Fang Z, , Wang F, et al. Galectin-9 significantly prolongs the survival of fully mismatched cardiac allografts in mice. Transplantation, 2009; 88: 782-790.","journal-title":"Transplantation"},{"key":"e_1_3_1_66_2","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.intimp.2008.11.013","article-title":"Detection of the TIM-3 ligand, galectin-9, inside the allograft during a rejection episode","volume":"9","author":"Naka EL","year":"2009","unstructured":"Naka EL, , Ponciano VC, , Cenedeze MA, et al. Detection of the TIM-3 ligand, galectin-9, inside the allograft during a rejection episode. Int Immunopharmacol, 2009; 9: 658-662.","journal-title":"Int Immunopharmacol"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.157.9.4258"},{"key":"e_1_3_1_68_2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1034\/j.1600-6143.2002.20306.x","article-title":"Prevention of acute lung allograft rejection in rat by CTLA4Ig","volume":"2","author":"Shiraishi T","year":"2002","unstructured":"Shiraishi T, , Yasunami Y, , Takehara M, et al. Prevention of acute lung allograft rejection in rat by CTLA4Ig. Am J Transplant, 2002; 2: 223-228.","journal-title":"Am J Transplant"},{"key":"e_1_3_1_69_2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1164\/ajrccm.165.5.2107084","article-title":"Blockade of CD28\/B7-2 costimulation inhibits experimental obliterative bronchiolitis in rat tracheal allografts: suppression of helper T cell type 1-dominated immune response","volume":"165","author":"Tikkanen JM","year":"2002","unstructured":"Tikkanen JM, , Lemstrom KB, , Koskinen PK. Blockade of CD28\/B7-2 costimulation inhibits experimental obliterative bronchiolitis in rat tracheal allografts: suppression of helper T cell type 1-dominated immune response. Am J Respir Crit Care Med, 2002; 165: 724-729.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050085"},{"key":"e_1_3_1_71_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.10.5211"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-3010"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2181"},{"key":"e_1_3_1_74_2","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1182\/blood-2010-08-302034","article-title":"Sezary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-beta on the cell surface","volume":"117","author":"Chung JS","year":"2011","unstructured":"Chung JS, , Shiue LH, , Duvic M, et al. Sezary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-beta on the cell surface. Blood, 2011; 117: 3382-3390.","journal-title":"Blood"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466"},{"key":"e_1_3_1_76_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-2538"},{"key":"e_1_3_1_77_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192461099"},{"key":"e_1_3_1_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm730"},{"key":"e_1_3_1_79_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.7609"},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0915174107"}],"container-title":["Dermatitis\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0b013e31826e43ed","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1097\/DER.0b013e31826e43ed","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0b013e31826e43ed","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:07:53Z","timestamp":1777399673000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0b013e31826e43ed"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,1]]},"references-count":79,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10,1]]}},"alternative-id":["10.1097\/DER.0b013e31826e43ed"],"URL":"https:\/\/doi.org\/10.1097\/der.0b013e31826e43ed","relation":{},"ISSN":["1710-3568","2162-5220"],"issn-type":[{"value":"1710-3568","type":"print"},{"value":"2162-5220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,1]]}}}